| Price | 9.40p on 13-04-2026 at 17:45:09 |
|---|---|
| Change | -0.04p -0.42% |
| Buy | 9.50p |
| Sell | 9.30p |
| Last Trade: | Sell 100,000.00 at 9.30p |
| Day's Volume: | 1,962,526 |
| Last Close: | 9.40p |
| Open: | 9.40p |
| ISIN: | GB00BYV81293 |
| Day's Range | 9.40p - 9.40p |
| 52wk Range: | 2.20p - 12.35p |
| Market Capitalisation: | £100.43m |
| VWAP: | 9.328114p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 100,000 | 9.30p | Ordinary |
16:43:52 - 13-Apr-26 |
| Unknown* | 500,000 | 9.30p | Ordinary |
16:42:40 - 13-Apr-26 |
| Unknown* | 24,886 | 9.40p | Uncrossing Trade |
16:35:06 - 13-Apr-26 |
| Buy* | 526 | 9.50p | Ordinary |
16:20:15 - 13-Apr-26 |
| Buy* | 10,524 | 9.44p | Ordinary |
15:30:49 - 13-Apr-26 |
| Sell* | 214,076 | 9.34p | Ordinary |
15:12:42 - 13-Apr-26 |
| Buy* | 20,000 | 9.45p | Ordinary |
14:57:58 - 13-Apr-26 |
| Buy* | 10,000 | 9.4445p | Ordinary |
14:37:01 - 13-Apr-26 |
| Sell* | 100,000 | 9.35p | Ordinary |
14:34:38 - 13-Apr-26 |
| Sell* | 21,444 | 9.35p | Ordinary |
14:10:17 - 13-Apr-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
| 9th Feb 2026 7:00 am | RNS | FDA Grants additional Exclusivity for ACCRUFeR |
| 30th Jan 2026 7:05 am | RNS | Total Voting Rights |
| 30th Jan 2026 7:00 am | RNS | Approval for ACCRUFeR in China expected in Q1 2026 |
| 21st Jan 2026 7:00 am | RNS | Q4 2025 Trading Update |
